Skip to content

Comparing Aurondo Mauritanica 6X and Constitutional Homoeopathic remedies in Allergic Rhinitis

Exploring the Efficacy of Arundo Mauritanica 6X By Olfaction Method versus Constitutional Homoeopathic Remedies in the Treatment of Perennial Allergic Rhinitis - NIL

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068715
Enrollment
60
Registered
2024-06-11
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J308- Other allergic rhinitis

Interventions

Intervention1: Arundo Mauritanica 6X: 1.Arundo mauritanica 6X by olfaction method will be given to group A patient is asked to inhale 5 medicated globules along with constitutional homoeopathic remed

Sponsors

KAHER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Subject presenting with the Symptoms of Allergic Rhinitis of grading more than 5. 2. Age between 18 to 60 years 3. both sex 4. Subject consenting to treatment.

Exclusion criteria

Exclusion criteria: 1. Subject presenting with the symptom of Allergic Rhinitis of grading less than 5. 2.Cases with gross nasal pathological changes like DNS, Nasal polyps, chronic sinusitis, any other nasal tumours 3.Complications affecting the lower respiratory system like pneumonia, asthma etc. 4.Subject on immune suppressants. 5. Associated with Systemic diseases, pregnant and lactating woman.

Design outcomes

Primary

MeasureTime frame
To assess the effectiveness of Arundo Muritanica 6X via nasal route by olfaction method along with the constitutional Homoeopathic remidiesTimepoint: 6 months

Secondary

MeasureTime frame
To compare the efficacy of Arundo Muritanica 6X by olfaction method with the Constitutional Homoeopathoc remediesTimepoint: 2 year

Countries

India

Contacts

Public ContactDr Supriya Kulkarni

KLE Homoeopathic Medical College and Hospital

kulkarnijsupriya30@gmail.com8050440537

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026